US Pandemic Relief Package Delivers OTC Industry Regulatory Wishes, Supplement Business Hopes
Executive Summary
It’s unlikely any industry stakeholder or FDA official expected a bill providing emergency economic relief to consumers, industries and health care services and facilities in response to a pandemic, including extensive support opportunities for small businesses, would be the vehicle that delivers on both of the industry’s congressional wishes. The supplement industry also looks for help in CARES Act.
You may also be interested in...
In Proposed Appropriation, Congress Tells FDA To Repurpose $7M For Cosmetic Regulation
Proposed budget agreement by House and Senate leaders comes four days before funding ends under the latest continuing resolution to keep the federal government open and a week before the White House plans to release its FY2025 budget request.
First US OTC Oral Contraceptive, Opill Marks Start Of Perrigo's Women’s Health ‘Mega-Brand’
“We do want to be a mega brand offering solutions across the women's sexual health journey. From the moment she enters into that category all the way through to post menopause, including fertility, we will develop out a mega brand,” says CEO Patrick Lockwood-Taylor.
Senate Democrats Push To Strike Insurers’ Option To Require Prescriptions For OTC Contraceptives
In letter to departments of Health and Human Services, Labor and Treasury, 47 of 48 Democrats and one of the three independents say allowing insurers the option “significantly reduces the advantages to consumers of an OTC product.”